222 related articles for article (PubMed ID: 27656018)
1. Involvement of Spinal IL-6 Trans-Signaling in the Induction of Hyperexcitability of Deep Dorsal Horn Neurons by Spinal Tumor Necrosis Factor-Alpha.
König C; Morch E; Eitner A; Möller C; Turnquist B; Schaible HG; Ebersberger A
J Neurosci; 2016 Sep; 36(38):9782-91. PubMed ID: 27656018
[TBL] [Abstract][Full Text] [Related]
2. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord.
Kawasaki Y; Zhang L; Cheng JK; Ji RR
J Neurosci; 2008 May; 28(20):5189-94. PubMed ID: 18480275
[TBL] [Abstract][Full Text] [Related]
3. Spinal interleukin-6 is an amplifier of arthritic pain in the rat.
Vazquez E; Kahlenbach J; Segond von Banchet G; König C; Schaible HG; Ebersberger A
Arthritis Rheum; 2012 Jul; 64(7):2233-42. PubMed ID: 22246633
[TBL] [Abstract][Full Text] [Related]
4. Involvement of microglial P2X7 receptors and downstream signaling pathways in long-term potentiation of spinal nociceptive responses.
Chu YX; Zhang Y; Zhang YQ; Zhao ZQ
Brain Behav Immun; 2010 Oct; 24(7):1176-89. PubMed ID: 20554014
[TBL] [Abstract][Full Text] [Related]
5. Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production.
Igaz P; Horváth A; Horváth B; Szalai C; Pállinger E; Rajnavölgyi E; Tóth S; Rose-John S; Falus A
Immunol Lett; 2000 Mar; 71(3):143-8. PubMed ID: 10722865
[TBL] [Abstract][Full Text] [Related]
6. Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling.
Hashizume M; Mihara M
Rheumatol Int; 2009 Feb; 29(4):397-401. PubMed ID: 18802703
[TBL] [Abstract][Full Text] [Related]
7. Spinal prostaglandins are involved in the development but not the maintenance of inflammation-induced spinal hyperexcitability.
Vasquez E; Bär KJ; Ebersberger A; Klein B; Vanegas H; Schaible HG
J Neurosci; 2001 Nov; 21(22):9001-8. PubMed ID: 11698610
[TBL] [Abstract][Full Text] [Related]
8. Sensitization of unmyelinated sensory fibers of the joint nerve to mechanical stimuli by interleukin-6 in the rat: an inflammatory mechanism of joint pain.
Brenn D; Richter F; Schaible HG
Arthritis Rheum; 2007 Jan; 56(1):351-9. PubMed ID: 17195239
[TBL] [Abstract][Full Text] [Related]
9. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17.
Hashizume M; Hayakawa N; Mihara M
Rheumatology (Oxford); 2008 Nov; 47(11):1635-40. PubMed ID: 18786965
[TBL] [Abstract][Full Text] [Related]
10. Bispecific soluble cytokine receptor-nanobody fusions inhibit Interleukin (IL-)6 trans-signaling and IL-12/23 or tumor necrosis factor (TNF) signaling.
Gesiorowski A; Ettich J; Werner J; Wittich C; Pieper S; Padrini G; Behnke K; Floss DM; Lang PA; Moll JM; Scheller J
J Biol Chem; 2023 Nov; 299(11):105343. PubMed ID: 37838173
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor.
Garbers C; Thaiss W; Jones GW; Waetzig GH; Lorenzen I; Guilhot F; Lissilaa R; Ferlin WG; Grötzinger J; Jones SA; Rose-John S; Scheller J
J Biol Chem; 2011 Dec; 286(50):42959-70. PubMed ID: 21990364
[TBL] [Abstract][Full Text] [Related]
12. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639
[TBL] [Abstract][Full Text] [Related]
13. Different effects of spinally applied prostaglandin D2 on responses of dorsal horn neurons with knee input in normal rats and in rats with acute knee inflammation.
Telleria-Diaz A; Ebersberger A; Vasquez E; Schache F; Kahlenbach J; Schaible HG
Neuroscience; 2008 Sep; 156(1):184-92. PubMed ID: 18678231
[TBL] [Abstract][Full Text] [Related]
14. The direction of synaptic plasticity mediated by C-fibers in spinal dorsal horn is decided by Src-family kinases in microglia: the role of tumor necrosis factor-alpha.
Zhong Y; Zhou LJ; Ren WJ; Xin WJ; Li YY; Zhang T; Liu XG
Brain Behav Immun; 2010 Aug; 24(6):874-80. PubMed ID: 20116424
[TBL] [Abstract][Full Text] [Related]
15. Role of spinal microglia in myositis-induced central sensitisation: an immunohistochemical and behavioural study in rats.
Chacur M; Lambertz D; Hoheisel U; Mense S
Eur J Pain; 2009 Oct; 13(9):915-23. PubMed ID: 19095475
[TBL] [Abstract][Full Text] [Related]
16. Exogenous tumor necrosis factor-alpha induces abnormal discharges in rat dorsal horn neurons.
Onda A; Hamba M; Yabuki S; Kikuchi S
Spine (Phila Pa 1976); 2002 Aug; 27(15):1618-24; discussion 1624. PubMed ID: 12163721
[TBL] [Abstract][Full Text] [Related]
17. Involvement of microglia and interleukin-18 in the induction of long-term potentiation of spinal nociceptive responses induced by tetanic sciatic stimulation.
Chu YX; Zhang YQ; Zhao ZQ
Neurosci Bull; 2012 Feb; 28(1):49-60. PubMed ID: 22233889
[TBL] [Abstract][Full Text] [Related]
18. Involvement of substance P and neurokinin-1 receptors in the hyperexcitability of dorsal horn neurons during development of acute arthritis in rat's knee joint.
Neugebauer V; Weiretter F; Schaible HG
J Neurophysiol; 1995 Apr; 73(4):1574-83. PubMed ID: 7643168
[TBL] [Abstract][Full Text] [Related]
19. Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130.
Tenhumberg S; Waetzig GH; Chalaris A; Rabe B; Seegert D; Scheller J; Rose-John S; Grötzinger J
J Biol Chem; 2008 Oct; 283(40):27200-7. PubMed ID: 18650419
[TBL] [Abstract][Full Text] [Related]
20. Effects of omega-agatoxin IVA, a P-type calcium channel antagonist, on the development of spinal neuronal hyperexcitability caused by knee inflammation in rats.
Nebe J; Ebersberger A; Vanegas H; Schaible HG
J Neurophysiol; 1999 Jun; 81(6):2620-6. PubMed ID: 10368382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
